Latest Blog Posts
Search
Sort Results
Filter by Specific Population
Filter by Topic
Filter by Infection
Filter by Resource Category
- Research summary (remove)
Search results
Current filters: HIV, Treatment, Research summary, HIV drugs
104 search results
- Biktarvy begins to get listed on provincial drug formularies
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - Dovato approved in Canada for HIV treatment
-
2019, CATIE
Research summary - Webpage - Truvada vs. Descovy for HIV prevention
-
From TreatmentUpdate 231
2019, CATIE
Research summary - Webpage - Higher levels of dolutegravir in older people not linked to side effects
-
From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage - Large French study examines neuropsychiatric side effects with integrase inhibitors
-
From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage - Can high-dose dolutegravir be a rescue therapy?
-
From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage - De-simplifying single-tablet regimens for HIV treatment
-
2019, CATIE
Research summary - Webpage - Italian study explores dual drug regimens as maintenance treatment
-
From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage - Dual maintenance therapy with dolutegravir + rilpivirine
-
From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage - Dolutegravir + 3TC for the initial treatment of HIV
-
From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage
